Evidence map›Paper›PMID 35303118›Full record

ArticleIntensive care medicine2022

Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.

Stefan Hagel, Friedhelm Bach, Thorsten Brenner, Hendrik Bracht, Alexander Brinkmann, Thorsten Annecke, Andreas Hohn, Markus Alexander Weigand, Guido Michels, Stefan Kluge and 14 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 3 countries.

Stefan HagelInstitute for Infectious Diseases and Infection Control, Jena University Hospital-Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany. stefan.hagel@med.uni-jena.de.ORCID http://orcid.org/0000-0003-2999-6131
Friedhelm BachDepartment of Infectious Diseases, Evangelisches Klinikum Bethel, Bielefeld, Germany.
Thorsten BrennerDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Hendrik BrachtDepartment of Anaesthesiology and Critical Care Medicine, University Hospital of Ulm, Ulm, Germany.
Alexander BrinkmannDepartment of Anaesthesiology and Intensive Care Medicine, General Hospital of Heidenheim, Heidenheim, Germany.
Thorsten AnneckeDepartment of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Andreas HohnDepartment of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Markus Alexander WeigandDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Guido MichelsDepartment of Acute and Emergency Care, St.-Antonius-Hospital gGmbH, Eschweiler, Germany.
Stefan KlugeDepartment of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Axel NierhausDepartment of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Dominik JarczakDepartment of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Christina KönigDepartment of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Dirk WeismannMedizinische Klinik Und Poliklinik I, Internistische Notfall- und Intensivmedizin, Universitätsklinikum Würzburg, Würzburg, Germany.
Otto FreyDepartment of Pharmacy, General Hospital of Heidenheim, Heidenheim, Germany.
Dominic WitzkeDepartment of Infectious Diseases, Evangelisches Klinikum Bethel, Bielefeld, Germany.
Carsten MüllerCentre of Pharmacology, Department of Therapeutic Drug Monitoring, University Hospital of Cologne, Cologne, Germany.
Michael BauerDepartment of Anesthesiology and Intensive Care Therapy, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.
Michael KiehntopfDepartment of Clinical Chemistry and Laboratory Medicine, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.
Sophie NeugebauerCenter for Sepsis Control and Care (CSCC), Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.
Thomas LehmannInstitute of Medical Statistics, Computer Sciences and Data Sciences, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.
Jason A RobertsUniversity of Queensland Centre for Clinical Research, and School of Pharmacy, University of Queensland, Brisbane, Australia.
Mathias W PletzInstitute for Infectious Diseases and Infection Control, Jena University Hospital-Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany.
TARGET Trial Investigators
Jena University Hospital · DEUniversität Hamburg · DEHeidelberg University · DEUniversity of Cologne · DEEvangelisches Krankenhaus Bielefeld · DESankt-Antonius-Hospital Eschweiler · DEThe University of Queensland · AUUniversitätsklinikum Würzburg · DEUniversity Hospital Cologne · DEUniversity Hospital Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35303118
PMCPMC9050772
OpenAlexW4220787764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.